Skip to content

Author

Alpaslan Tasdogan

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Refined on-tissue chemical derivatization expands MALDI-MSI capabilities for spatial metabolomics of mammalian organs and metastatic tumors using EDC and 4-APEBA

Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) is widely used in metabolomics because it enables high-resolution spatial characterization of molecular distributions directly from tissue. Nevertheless, comprehensive analysis of small, polar metabolites remains difficult due to limited...

Antonia Fecke, Luiza Martins Nascentes Melo, Ann-Cathrin Groba et al. · 0 citations
Open access Sep 2026

MCT1 activity defines an aggressive metabolic phenotype and therapeutic target in non-small cell lung cancer

Lactate uptake through monocarboxylate transporter 1 (MCT1) is associated with aggressive disease in non-small cell lung cancer (NSCLC), but how lactate transport supports tumor metabolism remains incompletely understood. Integrating stable isotope tracing, metabolomics, and transcriptomics across patient tumors, anima...

Robert B. Cameron, Kristen E. Shema, Nathan Dubois et al. · 0 citations
Sep 2026

Bridging Speed and Confidence in Metabolomics: A Retention Time and MS2-Guided HILIC-Orbitrap Workflow

Personalized treatment strategies are rising within modern medicine approaches to dynamic and heterogeneous diseases such as cancer. Human metabolism is important for the understanding of these diseases and their mechanisms, but metabolomics remains often unused in multiomics approaches due to practical challenges in...

Jonas Rösler, Constantin P. Krempe, Feyza Cansiz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.